Kritische 8-K Meldungen
Stammdaten
Unternehmen
| Name | Bioventus Inc. |
|---|---|
| Ticker | BVS |
| CIK | 0001665988 |
Branche
| SIC-Code | 3841 |
|---|---|
| Beschreibung | Surgical & Medical Instruments & Apparatus |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Titel | Bioventus Inc. |
Status
| Zuletzt geprüft | 2026-03-23 02:57:29.193352 |
|---|
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-11 | McMurry-Heath Michelle | Director | Open Market Sale | -12,000 | 8.79 | -105,439.20 | -197,1% | |
| 2025-12-04 | NOHRA GUY P | Director | Open Market Sale | -10,000 | 7.57 | -75,658.00 | -141,4% | |
| 2025-12-04 | NOHRA GUY P | Director | Open Market Sale | -10,000 | 7.57 | -75,658.00 | -141,4% | |
| 2025-11-07 | McMurry-Heath Michelle | Director | Open Market Sale | -17,701 | 7.42 | -131,254.69 | -245,3% | |
| 2025-04-11 | CHURCH KATRINA J | Officer, SVP & Chief Compliance Officer | Open Market Sale | -1,283 | 7.57 | -9,712.31 | -18,2% | |
| 2025-04-11 | Singleton Mark Leonard | Officer, SVP & CFO | Open Market Sale | -3,875 | 7.57 | -29,333.75 | -54,8% | |
| 2025-04-11 | D'Adamio Anthony | Officer, SVP & General Counsel | Open Market Sale | -2,958 | 7.57 | -22,392.06 | -41,8% | |
| 2025-04-11 | D'Adamio Anthony | Officer, SVP & General Counsel | Open Market Sale | -2,958 | 7.57 | -22,392.06 | -41,8% | |
| 2025-04-11 | CHURCH KATRINA J | Officer, SVP & Chief Compliance Officer | Open Market Sale | -1,283 | 7.57 | -9,712.31 | -18,2% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.